3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
2
Recurrence
1
Non-Small Cell Lung Cancer ALK-positive
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Astrocytoma
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
Cyclophosphamide
14
Magnetic Resonance Spectroscopy
10
Temozolomide
9
Biopsy
9
dinutuximab
8
X-Rays
8
Specimen Handling
8
Phantoms, Imaging
7
Irinotecan
7
fludarabine
6
Topotecan
6
Nuclear Medicine Department, Hospital
6
Vincristine
5
3-Iodobenzylguanidine
5
sargramostim
4
fludarabine phosphate
4
Melphalan
4
Isotretinoin
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Etoposide
4
tipifarnib
3
Radiotherapy
3
Filgrastim
3
Doxorubicin
3
Colony-Stimulating Factors
3
Carboplatin
3
ulixertinib
2
tazemetostat
2
selpercatinib
2
saponin QA-21V1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
lorlatinib
×
90 days
×
Clear all
No trials found.